Nozuko Blasich | HIV and Mycology | Best Researcher Award

Posted on by ScienceFather

Ms. Nozuko Blasich | HIV and Mycology | Best Researcher Award

Quality Control Technologist, National Health Laboratory Service South Africa

Nozuko Blasich is a Clinical Pathology Medical Technologist specializing in laboratory diagnostics, quality control, and biomedical research. She holds a Master of Science in Biomedical Technology and is currently pursuing a PhD in Biomedical Science, focusing on fungal pathogens and their public health impact. Her research on cryptococcal meningitis has influenced World Health Organization (WHO) policies. She has published in high-impact journals, presented at international conferences, and serves as a peer reviewer. Passionate about improving diagnostic accuracy, she explores point-of-care tests for infectious diseases.

Profile

Orcid

Education 🎓

Nozuko Blasich earned her Master of Science in Biomedical Technology, with research focusing on cryptococcal meningitis, significantly contributing to global health policies. She is currently a PhD candidate in Biomedical Science, investigating fungal pathogens and their environmental prevalence. Her academic journey emphasizes microbiology, clinical diagnostics, and public health.

Experience 🧑‍🏫

She serves as a Quality Control Technologist at the National Health Laboratory Service, ensuring diagnostic accuracy and laboratory efficiency. With expertise in mycology, she has worked extensively on cryptococcal antigen screening and HIV diagnostics.

 Awards & Honors 🏆

She has received recognition for her contributions to medical mycology, including best researcher awards and grants for her impactful studies on fungal pathogens and diagnostic advancements.

Research Interests 🔬

Her research explores fungal infections, laboratory diagnostics, and point-of-care testing to enhance public health interventions. She investigates diagnostic methodologies, antimicrobial resistance, and epidemiology to improve early detection and treatment outcomes.

Publications 📚

  1. Evaluating the Accuracy of Multiple Rapid Diagnostic Tests for HIV Detection in Serum Samples Analysed During Point-of-Care Proficiency Testing Assessments (2025) – Nozuko P. Blasich, Jerom Okot, Artur Ramos, Mduduzi B. Buthelezi, Dumisani F. Shabangu, Mahlatse M. Maleka, Sarvashni Moodliar, Nqobile Ngoma, Tendesayi Kufa

 

  1. Retrospective Assessment of a National Reflex Cryptococcal Antigen Screening Program in South Africa Through Interlaboratory Comparison of Lateral Flow Assay Results (2022) – Nozuko P. Blasich, Lindi M. Coetzee, Charlotte Sriruttan, Daniel DeSanto, Gregory S. Greene, Deborah K. Glencross, Nelesh P. Govender

 

  1. Association of Semi-Quantitative Cryptococcal Antigen Results in Plasma with Subclinical Cryptococcal Meningitis and Mortality Among Patients with Advanced HIV Disease (2021) – Nozuko P. Blasich, Rachel M. Wake, Ivy Rukasha, Yvonne Prince, Nelesh P. Govender

 

  1. Cryptococcus neoformans: Diagnostic Dilemmas, Electron Microscopy and Capsular Variants (2018) – Nozuko P. Blasich, Monica Birkhead, Serisha D. Naicker, Ivy Rukasha, Juno Thomas, Charlotte Sriruttan, Shareef Abrahams, Grisselda S. Mavuso, Nelesh P. Govender

 

Anastasia Kovrizhina | Medicinal chemistry | Women Researcher Award

Posted on by ScienceFather

Dr. Anastasia Kovrizhina | Medicinal chemistry | Women Researcher Award

PhD Reseracher, Tomsk Polytechnic University Russia

Anastasia Kovrizhina is a Russian researcher specializing in organic chemistry and biotechnology. She holds a Ph.D. from National Research Tomsk Polytechnic University, where she focuses on molecular modeling and the synthesis of biologically active compounds. Currently, she is a researcher at Tomsk Polytechnic University and serves as a scientist secretary. Her work includes the development of novel kinase inhibitors and fluorocarbon aza-heterocycles for anticancer treatments. She has been actively involved in international collaborations, including research internships at Montana State University, USA, and Novosibirsk Institute of Organic Chemistry, Russia. With an h-index of 7, she has published extensively in high-impact journals and has presented at numerous international and national conferences. She has received multiple prestigious scholarships and awards, including the Baden-Württemberg State Scholarship and the Government Scholarship of the Russian Federation. Her expertise spans chemical synthesis, biological assays, computational chemistry, and quantum calculations.

Profile

Scopus

Education 🎓

Anastasia Kovrizhina earned her Ph.D. (2019-2023) in Organic Chemistry from National Research Tomsk Polytechnic University, specializing in molecular modeling and drug synthesis. She completed her Master’s degree (2017-2019) in Biotechnology at the same institution, where she studied organic and applied chemistry. During her studies, she participated in an academic exchange at Karlsruhe Institute of Technology, Germany, where she took courses in bioinformatics, bioprocessing, and enzymology. She obtained her Bachelor’s degree (2013-2017) in Biotechnology from National Research Tomsk Polytechnic University, with a strong foundation in chemistry, physics, and humanities. Her academic journey has been complemented by advanced training in computational chemistry, quantum calculations, and SAR/QSAR analysis. She has also gained international exposure through scholarships and research projects focused on innovative drug development. Her multidisciplinary education allows her to integrate experimental and computational approaches for pharmaceutical and medical applications.

Experience 🧑‍🏫

Anastasia Kovrizhina is currently a researcher at Tomsk Polytechnic University, specializing in the synthesis of biologically active compounds. She also serves as a scientist secretary at the School of Advanced Manufacturing Technologies and is an active member of the Council of Young Scientists. She has undertaken research internships at the Novosibirsk Institute of Organic Chemistry (2020) and Montana State University, USA (2019), where she collaborated on immunology and organic chemistry projects. Her work includes grant-funded research on kinase inhibitors, fluorocarbon aza-heterocycles, and polymer scaffolds for cardiovascular applications. She has supervised undergraduate and master’s students and has taught courses in professional English and organic chemistry. Her expertise includes molecular modeling, chemical synthesis, and computational chemistry. She has contributed to multiple research projects under the Russian Science Foundation and has been instrumental in developing innovative drug delivery systems for anticancer treatments.

 Awards & Honors 🏆

Anastasia Kovrizhina has received several prestigious awards, including the First Degree Diploma (2024) for her research on indenoquinoxalinone oxime (IQ-1). She won the 5th All-Russian Research Competition (2020) for her work on indenoquinoxaline derivatives. She was honored with the 3rd Degree Medal for “Achievements for Tomsk Polytechnic University” and the BAYHOST Scholarship for studying German (2020). She received the Baden-Württemberg State Scholarship (2018-2019) and the Russian Government Scholarship (2018-2019). Her participation in international conferences has been recognized with numerous accolades. She has also secured multiple research grants, including the Russian Science Foundation grants for developing kinase inhibitors and fluorocarbon aza-heterocycles as anticancer agents. Her scientific contributions to drug discovery and pharmaceutical chemistry have positioned her as a promising young researcher in her field.

Research Interests 🔬

Anastasia Kovrizhina’s research focuses on the synthesis and molecular modeling of biologically active compounds, particularly kinase inhibitors and fluorocarbon aza-heterocycles for anticancer treatments. She has pioneered the development of JNK kinase inhibitors based on indenoquinoxaline scaffolds, which have potential anti-inflammatory applications. Her work has demonstrated that IQ-1 salts enhance the efficacy of cerebral ischemia treatment. She has conducted pharmacokinetic studies on IQ-1 absorption in the gastrointestinal tract to optimize drug formulation. Her expertise extends to computational chemistry, quantum calculations, and structure-activity relationship (SAR) studies. She is also involved in developing supramolecular complexes for innovative drug delivery. Her interdisciplinary approach integrates synthetic chemistry, computational modeling, and biological assays to advance pharmaceutical research. She has contributed significantly to drug design, molecular docking studies, and the synthesis of novel heterocyclic compounds for targeted therapies.

Publications 📚

  1. Title: 6,8-Dibromo-11H-indeno[1,2-b]quinolin-11-one
    Year: 2024
    Author: Anastasia R. Kovrizhina, Dauren Tolegen, Dmitry I. Pavlov, Andrei S. Potapov, Andrei I. Khlebnikov
    Citations: Not available
    Article: Molbank

 

  1. Title: Evaluation of Nitric Oxide-Donating Properties of 11H-indeno[1,2-b]quinoxalin-11-one Oxime (IQ-1) by Electron Paramagnetic Resonance Spectroscopy
    Year: 2024
    Author: Viacheslav V. Andrianov, Igor A. Schepetkin, Leah V. Bazan, Khalil L. Gainutdinov, Anastasia R. Kovrizhina, Dmitriy N. Atochin, Andrei I. Khlebnikov
    Citations: Not available
    Article: Molecules

 

  1. Title: Dose proportionality and bioavailability of quinoxaline-based JNK inhibitor after single oral and intravenous administration in rats
    Year: 2024
    Author: Galina A. Frelikh, Elena A. Yanovskaya, Alexander P. Lakeev, Galina A. Chernysheva, Vera I. Smolyakova, Anastasia R. Kovrizhina
    Citations: Not available
    Article: Xenobiotica

 

  1. Title: Neuroprotective Effects of Tryptanthrin-6-Oxime in a Rat Model of Transient Focal Cerebral Ischemia
    Year: 2023
    Author: Mark Plotnikov, Galina A. Chernysheva, Vera I. Smol’yakova, Oleg I. Aliev, Anna M. Anishchenko, Olga A. Ulyakhina, Eugene S. Trofimova, Anastasia A. Ligacheva, Nina D. Anfinogenova, Anton Osipenko et al.
    Citations: Not available
    Article: Pharmaceuticals

 

  1. Title: Novel Tryptanthrin Derivatives with Selectivity as c–Jun N–Terminal Kinase (JNK) 3 Inhibitors
    Year: 2023
    Author: Igor A. Schepetkin, Oleksander S. Karpenko, Anastasia R. Kovrizhina, Liliya N. Kirpotina, Andrei I. Khlebnikov, Stepan I. Chekal, Alevtyna V. Radudik, Maryna O. Shybinska, Mark T. Quinn
    Citations: Not available
    Article: Molecules

 

  1. Title: Quantification of a promising JNK inhibitor and nitrovasodilator IQ-1 and its major metabolite in rat plasma by LC–MS/MS
    Year: 2022
    Author: Alexander P. Lakeev, Galina A. Frelikh, Elena A. Yanovskaya, Anastasia R. Kovrizhina, Vladimir V. Udut
    Citations: Not available
    Article: Bioanalysis

 

  1. Title: Poly(ϵ-caprolactone) Scaffolds Doped with c-Jun N-terminal Kinase Inhibitors Modulate Phagocyte Activation
    Year: 2019
    Author: K.S. Stankevich, I.A. Schepetkin, S.I. Goreninskii, A.K. Lavrinenko, E.N. Bolbasov, A.R. Kovrizhina, L.N. Kirpotina, V.D. Filimonov, A.I. Khlebnikov, S.I. Tverdokhlebov et al.
    Citations: Not available
    Article: ACS Biomaterials Science and Engineering

 

Ildoo Chung | Pharmacology | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. Ildoo Chung | Pharmacology | Best Researcher Award

 Professor, Pusan National University South Korea

Ildoo Chung is a distinguished professor in the Department of Polymer Science and Engineering at Pusan National University, Korea. With a career spanning over two decades, he specializes in polymer chemistry, functional materials, and advanced biomedical engineering applications. Dr. Chung has held prominent academic and administrative positions, including department head and associate dean. He actively contributes to global research through editorial roles, conference leadership, and professional society memberships. Renowned for his dedication to education and innovation, Dr. Chung’s work bridges academia and industry, advancing polymer science worldwide.

Publication Profile

Scopus

Orcid

google scholar

🎓 Education

Ph.D. in Polymer Science & Engineering, Pusan National University, Korea (2000.08). M.S. in Polymer Science & Engineering, Pusan National University, Korea (1997.02). B.S. in Polymer Science & Engineering, Pusan National University, Korea (1995.02)

💼 Experience

Professor, Pusan National University, Korea (2014–present). Associate Dean, College of Engineering, Pusan National University (2018–2020). Department Head, Polymer Science & Engineering, Pusan National University (2013–2017). Visiting Associate Professor, University of Tennessee, USA (2012–2013). Assistant/Associate Professor, Pusan National University (2005–2014). Postdoctoral Fellow, University of Alabama at Birmingham, USA (2000–2002)

🏆 Awards & Honors

Member, Board of Directors, The Polymer Society of Korea. Editorial roles in Journal of Adhesion and Interface, IJMSE, and others. Numerous conference chair and committee memberships globally. Reviewer for high-impact journals like Macromolecular Research and Dental Materials. Recipient of national and international recognition for polymer research

🔬 Research Focus

Development of functional polymers for drug delivery and biomedical applications. Advanced polymer composites and their industrial applications. Interface engineering in polymer systems for sustainability. Nanostructured materials and their multifunctional properties. Polymer chemistry for healthcare innovations

Conclusion

Professor Ildoo Chung’s academic and professional journey reflects a commitment to advancing knowledge in polymer science and materials engineering. His leadership, research, and editorial work have significantly impacted the field, making him a deserving candidate for the Best Researcher Award. With continued efforts in interdisciplinary collaboration and practical applications, he has the potential to further elevate his influence and contributions to global scientific advancements.

Publication Top Notes

  • Title: L-Threonine-Derived Biodegradable Polyurethane Nanoparticles for Sustained Carboplatin Release
    Year: 2024
    Authors: Seoeun Oh, Soo-Yong Park, Hyung Il Seo, Ildoo Chung
    Citation: DOI: 10.3390/pharmaceutics17010028

 

  • Title: Derivatization of Hyaluronan to Target Neuroblastoma and Neuroglioma Expressing CD44
    Year: 2024
    Authors: Vo Van Giau, Giau Van Vo, Van-Giau Vo, Ildoo Chung, Chang-Sik Ha, Seong An, Yang H. Yun
    Citation: DOI: 10.3390/pharmaceutics16060836

 

  • Title: Depolymerized Chitosan-g-[Poly(MMA-co-HEMA-cl-EGDMA)] Based Nanogels for Controlled Local Release of Bupivacaine
    Year: 2023
    Authors: Sivagangi Reddy Nagella, Soojeong Choi, Soo-Yong Park, Chang-Sik Ha, Youngmi Jung, Ramesh Kumar Chitumalla, Joonkyung, Ji-Young Yoon, Ildoo Chung
    Citation: DOI: 10.3390/ijms242216470

 

  • Title: Effects of Recycled Polymer on Melt Viscosity and Crystallization Temperature of Polyester Elastomer Blends
    Year: 2023
    Authors: Ji-Eun Lee, Jin-Woo Lee, Jae-Wang Ko, Kyung-Il Jo, Hyun-Ju Park, Ildoo Chung
    Citation: DOI: 10.3390/ma16176067

 

  • Title: Carboxymethyl cellulose/montmorillonite bionanocomposite films incorporated with polyhedral oligomeric silsesquioxane
    Year: 2022
    Authors: Jin H., Yan Y.-Z., Lee C.S., Lee J.-H., Chung I., Ha C.-S.
    Citation: DOI: 10.1080/09276440.2022.2151262

 

  • Title: Effect of the Surface Modification of Silica Nanoparticles on the Viscosity and Mechanical Properties of Silica/Epoxy Nanocomposites
    Year: 2022
    Authors: Kim T., Kwon S.-H., Kim H.J., Lim C.-S., Chung I., Lee W.-K., Seo B.
    Citation: DOI: 10.1080/09276440.2022.2094572

 

  • Title: Polydopamine/Polypyrrole Modified Graphite Felt Enhances Biocompatibility for Electroactive Bacteria and Power Density of Microbial Fuel Cell
    Year: 2022
    Authors: Kim M., Li S., Kong D.S., Song Y.E., Park S.-Y., Kim H.-I., Jae J., Chung I., Kim J.R.
    Citation: EID: 2-s2.0-85133636105

 

  • Title: Polyol and Polyurethane Containing Bisphenol-Z: Synthesis and Application for Toughening Epoxy
    Year: 2022
    Authors: Lee D.Y., Kim H.J., Kim H.-G., Lim C.-S., Chung I., Seo B.
    Citation: DOI: 10.1002/app.53013

 

  • Title: ROS- and pH-Responsive Polydopamine Functionalized Ti₃C₂Tₓ MXene-Based Nanoparticles as Drug Delivery Nanocarriers with High Antibacterial Activity
    Year: 2022
    Authors: Wei-Jin Zhang, Shuwei Li, Veena Vijayan, Lee Jun Seok, Sung Soo Park, Xiuguo Cui, Ildoo Chung, Jaejun Lee, Suk-kyun Ahn, Jung Rae Kim, et al.
    Citation: DOI: 10.3390/nano12244392

 

  • Title: Dual (pH- and ROS-) Responsive Antibacterial MXene-Based Nanocarrier for Drug Delivery
    Year: 2022
    Authors: Wei-Jin Zhang, Shuwei Li, Yong-Zhu Yan, Sung Soo Park, Anandhu Mohan, Ildoo Chung, Suk-kyun Ahn, Jung Rae Kim, Chang-Sik Ha
    Citation: DOI: 10.3390/ijms232314925

 

 

Daniela Malengo | Pharmacology | Women Researcher Award

Posted on by ScienceFather

Dr. Daniela Malengo | Pharmacology | Women Researcher Award

Dr at Istituto Europeo di Oncologia, Italy

Daniela Malengo, an Italian pharmacist, is currently the Vice Director of the Hospital Pharmacy Division at Istituto Europeo di Oncologia, Milan. With a career spanning over 15 years, Daniela specializes in oncology drug management, hospital pharmacy administration, and medical device protocols. She is passionate about optimizing pharmaceutical practices and contributing to oncology care. Throughout her career, she has been dedicated to ensuring the safe and effective use of drugs in oncological treatments and has supported numerous research projects. Her leadership skills also extend to teaching pharmacy students through internships and projects.

Profile

Scopus

🎓 Education 

Management of CAR-T Patients, LIUC Business School (Dec 2023–Mar 2024). Hospital Pharmacy Management, Università Bocconi, Milan (Sept 2019–Dec 2020). Specialization in Applied Pharmacology, University of Pavia (2005–2009). Degree in Pharmacy, University of Pavia (2000–2005). State Exam for Pharmacist License, University of Pavia (Nov–Dec 2005). Scientific High School Diploma, Liceo Scientifico N. Copernico, Pavia (1995–2000)

💼 Experience

Vice Director of Hospital Pharmacy Division, Istituto Europeo di Oncologia, Milan (July 2023–Present): Managing narcotic drug dispensation and overseeing oncological therapy. Assistant Pharmacist, Istituto Europeo di Oncologia, Milan (Mar 2011–July 2023): Managed medical devices and chemotherapy prescriptions. Pharmacist – Research Fellow, Istituto Europeo di Oncologia, Milan (May 2006–Feb 2011): Supervised experimental drugs and contributed to research on oncological drug appropriateness. Intern (2004–2005): Worked at Farmacia Dott. A. Lodola, Siziano, dispensing medications to the public.

🏆 Awards & Honors

Numerous presentations at national congresses, including SIFO Congress (2009–2010). Recognized for contributions to hospital pharmacy management and cost analysis of oncological treatments. Leadership roles in pharmacy student internships and research programs. Awarded for excellence in promoting safe oncological drug usage.

🔬 Research Focus

Oncology Pharmacology: Focuses on managing oncological drug appropriateness, chemotherapy prescriptions, and medical device protocols. Pharmacy Management: Expertise in hospital pharmacy operations, including drug dispensation, quality control, and patient safety. Experimental Pharmacology: Managed experimental drugs and contributed to clinical research in oncological treatments. Cost Analysis: Focus on managing hospital pharmacy expenses and evaluating drug cost-effectiveness.

Conclusion

Daniela Malengo’s career exemplifies dedication to hospital pharmacy, oncological drug management, and the advancement of healthcare systems through her research and leadership roles. Her consistent contributions to improving patient outcomes in oncology, coupled with her academic excellence, make her a strong candidate for the Women Researcher Award. With her continued focus on improving the quality of healthcare services and mentoring future professionals, Daniela’s future contributions are poised to have a lasting impact in both the pharmacy and healthcare sectors.

📚Publications 

  • The Prolonged Clinical Benefit with Metronomic Chemotherapy (VEX Regimen) in Metastatic Breast Cancer Patients
    • Authors: Montagna, E., Pagan, E., Cancello, G., Viale, G., Colleoni, M.
    • Journal: Anti-Cancer Drugs
    • Volume: 33
    • Issue: 1
    • Pages: E628–E634
    • Year: 2022
    • Citations: 6

 

  • Management of Breast Cancer Patients During the Peak of the COVID-19 Pandemic
    • Authors: Montagna, E., Bellerba, F., Sangalli, C., Colleoni, M., Veronesi, P.
    • Journal: European Journal of Surgical Oncology
    • Volume: 47
    • Issue: 10
    • Pages: 2694–2695
    • Year: 2021
    • Citations: 2

 

Srijan Acharya | Molecular Pharmacology | Excellence in Research

Posted on by ScienceFather

Dr. Srijan Acharya | Molecular Pharmacology | Excellence in Research

Dr at St. Jude Children’s Research Hospital, United States

Srijan Acharya is a dedicated scientist with expertise in molecular pharmacology and cancer genomics. He is currently a Post-Doctoral Research Fellow at St. Jude Children’s Research Hospital, focusing on childhood cancer research. With 32 published scientific articles and a total citation count of over 385, his work has contributed significantly to biomarker discovery, receptor pharmacology, and immuno-oncology. His research aims to address therapeutic resistance in pediatric malignancies through small molecule screening. Srijan is fluent in English, Bangla, and Hindi, with basic knowledge of Korean.

Profile

Scholar

🎓 Education

PhD in Molecular Pharmacology from Chonnam National University, South Korea (2020). M.Sc. in Biotechnology from North South University, Bangladesh (2015). BPHRM in Pharmacy from East West University, Bangladesh (2012). His academic journey has provided a strong foundation in receptor pharmacology and molecular biology, guiding his transition into cancer research.

💼 Experience

Post-Doctoral Research Fellow, Pharmacy Department, St. Jude Children’s Research Hospital, USA (2023-Present). Post-Doctoral Research Fellow, Pathology Department, Mitchell Cancer Institute, USA (2020-2023). Executive Officer, Research and Development, Square Pharmaceutical PLC, Bangladesh (2012-2013). His experience spans academia and industry, with a focus on cancer research, receptor signaling, and small molecule screening.

🏆 Awards and Honors

Inducted into Sigma Xi, The Scientific Research Honor Society (2023). Recognized in Who’s Who in America by Marquis (2023). Young Investigator Award at AACR conference by AAISCR (2022). Best Presenter Award from China Pharmaceutical University (2021). Global Scholarship from Chonnam National University, Korea (2015). These accolades reflect his significant contributions to molecular pharmacology and cancer research.

🔬 Research Focus

Srijan’s research primarily investigates the role of molecular signaling in cancer, focusing on the interaction of nicotine receptors with GPCRs and their impact on cancer progression. At St. Jude, his work focuses on childhood cancers, particularly Ewing sarcoma and rhabdomyosarcoma. He uses small molecule screening to discover potential therapeutic agents and aims to overcome therapeutic resistance in pediatric cancers.

Conclusion

Srijan Acharya is a highly accomplished and promising researcher whose contributions to cancer pharmacology and molecular biology are noteworthy. His interdisciplinary research approach, combined with his dedication to advancing pediatric oncology, positions him as a leader in the field. With continued mentorship and broader collaborative efforts, Acharya is well poised for even greater achievements, further solidifying his place as an influential scientist in the biomedical community.

📚Publications 

  • Title: Unveiling the intracellular dynamics of α4β2 nAChR-mediated ERK activation through the interplay of arrestin, Gβγ, and PKCβII
    Year: 2024
    Authors: Dooti K, Acharya S, Wang S, Kim K.M.

 

  • Title: Biphasic transcriptional and posttranscriptional regulation of MYB by androgen signaling mediates its growth control in prostate cancer
    Year: 2023
    Authors: Acharya S, Anand S, Khan MA, Zubair H, Srivastava SK, Singh S, Singh AP

 

  • Title: MYB exhibits racially disparate expression, clinicopathologic association, and predictive potential for biochemical recurrence in prostate cancer
    Year: 2023
    Authors: Md Khan, S Acharya, S Anand, F Sameeta, P Pramanik, C Keel, S Singh, James E Carter, S Dasgupta, A Singh

 

  • Title: Comparative study of the molecular mechanisms underlying the G protein and β-arrestin-dependent pathways that lead to ERKs activation upon stimulation by dopamine D2 receptor
    Year: 2023
    Authors: Liu H, Acharya S, Sudan SK, Hu L, Wu C, Cao Y, Li H, Zhang X

 

  • Title: Frequent loss of cacna1c, a calcium voltage-gated channel subunit is associated with lung adenocarcinoma progression and poor prognosis
    Year: 2023
    Authors: Dasgupta, S., Acharya, S., Khan, M. A., Pramanik, P., Marbut, S. M., Yunus, F., Galeas, J. N., Singh, S., Singh, A. P., and Dasgupta, S.

 

  • Title: Nicotine causes alternative polarization of macrophages via Src-mediated STAT3 activation: Potential pathobiological implications
    Year: 2022
    Authors: Acharya S, Saranyutanon S, Deshmukh SK, Khan MA, Singh S, Singh AP

 

  • Title: β-Arrestin1 and GRK2 play permissive roles in Src-mediated endocytosis of α4β2 nicotinic acetylcholine receptor
    Year: 2021
    Authors: Acharya S, Kundu D, Kim KM

 

  • Title: Roles of the Functional Interaction between Brain Cholinergic and Dopaminergic Systems in the Pathogenesis and Treatment of Schizophrenia and Parkinson’s Disease
    Year: 2021
    Authors: Acharya S, Kim KM

 

  • Title: Clinicopathologic significance and race-specific prognostic association of MYB overexpression in ovarian cancer
    Year: 2021
    Authors: Miree, O., Srivastava, …Acharya S.et al.

 

  • Title: Metabotropic signaling cascade involved in α4β2 nicotinic acetylcholine receptor-mediated PKCβII activation
    Year: 2020
    Authors: Acharya S, D. Kundu, H.J. Choi, and K.M. Kim

 

  • Title: Catalpol and Mannitol, Two Components of Rehmannia glutinosa, Exhibit Anticonvulsant Effects Probably via GABAA Receptor Regulation
    Year: 2019
    Authors: Acharya S, Kim M., Botanas C. J., Custodio R. J., Lee H. J., Sayson L. V., Kim H. J.

 

  • Title: Design, synthesis and in vitro activity of 1,4-disubstituted piperazines and piperidines as triple reuptake inhibitors
    Year: 2017
    Authors: Paudel S, Acharya S, Yoon G, Kim K.M., & Cheon S.H.

 

N T Pramathesh Mishra | Pharmacology | Young Scientist Award

Posted on by ScienceFather

Assoc Prof Dr. N T Pramathesh Mishra | Pharmacology| Young Scientist Award

Associate Professor at Department of Pharmacology, Goel Institute of Pharmacy and Sciences, Lucknow, Uttar Pradesh, India, 226028

As an accomplished Associate Professor in Pharmacology, I aim to contribute to innovative scientific research, advanced drug discovery, and training future healthcare professionals . With over a decade of experience and recognition, including awards like the Daniel Bovet Distinguished Young Scientist Award and Karma Veer Chakra Global Youth Fellowship , I am dedicated to advancing pharmacology and fostering collaborative research initiatives . My goal is to engage in cutting-edge research, impactful workshops, and inspire the next generation of scientists and healthcare providers

Publication

    1. Effect of COVID-19 Pandemic Lockdowns on Planned Cancer Surgery for 15 Tumour Types in 61 Countries
      Journal: The Lancet Oncology
      Year: 2021
      Citations: 256

     

    1. Global Impacts of Pre-and Post-COVID-19 Pandemic: Focus on Socio-Economic Consequences
      Journal: Sensors International
      Year: 2020
      Citations: 140

     

    1. Endophyte-Mediated Modulation of Defense-Related Genes and Systemic Resistance in Withania somnifera (L.) Dunal Under Alternaria alternata Stress
      Journal: Applied and Environmental Microbiology
      Year: 2018
      Citations: 77

     

    1. Molecular Mechanisms and Therapeutic Strategies for Levodopa-Induced Dyskinesia in Parkinson’s Disease
      Journal: Frontiers in Pharmacology
      Year: 2022
      Citations: 30

     

    1. Supplementation of Trichoderma Improves the Alteration of Nutrient Allocation and Transporter Genes Expression in Rice Under Nutrient Deficiencies
      Journal: Plant Physiology and Biochemistry
      Year: 2019
      Citations: 23

     

    1. Clinicomycological Study of Dermatophytoses in Children Presenting at a Tertiary Care Center
      Journal: Indian Journal of Paediatric Dermatology
      Year: 2018
      Citations: 21

    Conclusion

    N T Pramathesh Mishra is a strong candidate for the Young Scientist Award due to his robust academic background, impactful research contributions, and recognition through prestigious awards. His diverse experience, innovative patents, and involvement in significant research projects reflect his potential as a leading young scientist. Addressing the areas for improvement, particularly in publication and broader collaboration, could further strengthen his candidacy and enhance his impact in the scientific community.

Divya Kumar | Clinical |Best Researcher Award

Posted on by ScienceFather

Dr. ‌Divya Kumar |Clinical| Best Researcher Award

Dr at McLean Hospital, United States

Divya Kumar is a dedicated clinical psychologist with a focus on affective disorders and behavioral interventions. Currently completing a Post-Doctoral Fellowship at McLean Hospital/Harvard Medical School, Divya’s research and clinical experiences span various settings, including academic institutions and healthcare facilities. With expertise in positive affect dysregulation and depression treatment, Divya has authored multiple peer-reviewed publications and presented at national conferences. Their commitment to teaching and mentorship is evident through roles as an instructor and teaching assistant. Divya’s comprehensive training and contributions to the field make them a valuable asset in clinical research and practice.

Profile

 

📚Education 

McLean Hospital/Harvard Medical School Belmont, MA Post-Doctoral Fellowship, Clinical Psychology July 2023 – Present Pre-Doctoral Intern, Clinical Psychology July 2022 – June 2023 Southern Methodist University Dallas, TX Doctoral Candidate, Clinical Psychology July 2023 Advisor: Alicia E. Meuret, Ph.D. Dissertation: A randomized controlled trial of brief behavioral activation plus savoring for positive emotion dysregulation in university students Master of Arts, Clinical Psychology August 2020 Advisor: Alicia E. Meuret, Ph.D. Thesis: Walking on the bright side: Associations between depression, affect, and gait Washington University in St. Louis St. Louis, MO Bachelor of Arts, Philosophy-Neuroscience-Psychology December 2014

Honours and awards 🏆

🏆 2024 Career Development Leadership Program Anxiety and Depression Association of America🎓 2017 – 2023 University Ph.D. Fellowship Award Southern Methodist University🏅 2022 Virginia Roswell Student Dissertation Award Association of Behavioral and Cognitive Therapies🔬 2019 President Partner’s Grant Southern Methodist University (CO-I: Alicia Meuret)🎖️ 2019 Honorable Mention for Graduate Research Fellowship Program National Science Foundation🥇 2019 Graduate Student Research Day Award Dedman College, Southern Methodist University

manuscripts in peer reviewed journals

Kumar, D., Corner, S., Kim, R., Meuret, A. (2024). A randomized controlled trial of brief behavioral activation plus savoring for positive affect dysregulation in university students. Behaviour Research and Therapy, 104525. Alvi, T., Kumar, D., Tabak, B. (2022). Social anxiety and behavioral assessments of social cognition: A systematic review. Journal of Affective Disorders, 311, 17-30. Kumar, D., Villarreal, D. J., Meuret, A. E. (2021). Walking on the bright side: Relations between depression, affect, and gait. PLoS one, 16(12), e0260893. Kumar, D., Tully, L.M., Iosif, A.M., Nye, K.E., Zakskorn, L.N., Zia, A., Niendam, T.A. (2018). A mobile health platform for clinical monitoring in early psychosis: implementation in community-based outpatient early psychosis care. Journal of Medical Internet Research Mental Health, 5(1): e15. Niendam, T.A., Tully, L.M., Iosif, A.M., Kumar, D., Burch, K., Denton, J., Zakskorn, L., Fedechko, T., Pierce, K. (2018). Enhancing early psychosis treatment using smartphone technology Part I: Feasibility and validity. Journal of Psychiatric Research, 96, 239-246.

Clinical Experience 🏥

Behavioral Health Partial Hospitalization Program, McLean Hospital Belmont, MA Psychology Intern | July 2022 – July 2023As a psychology intern, I provided brief intervention for patients in the partial hospital program, drawing skills from CBT, ACT, and DBT. Additionally, I led and co-led skills-based groups on empirically supported therapies weekly. Moreover, I provided individual ERP therapy through the McLean Obsessive Compulsive Disorder Institute as part of a 3-month rotation and individual psychotherapy through the McLean OnTrack Early Psychosis Clinic. 🩺Treatment for Affective Dimensions Study, Dallas, TX Study Therapist | August 2018 – June 2022In this role, I provided psychotherapy related to increasing positive affect through behavioral activation, positive cognitive strategies, and mindfulness practices. I also offered psychotherapy related to decreasing negative affect through inhibitory learning model exposures, cognitive restructuring, and respiratory biofeedback. Furthermore, I conducted structured diagnostic evaluations (SCID-5) for study intake. 🧠SMU Psychology Clinic, Dallas, TX
Advanced Practicum Student | June 2021 – June 2022At the SMU Psychology Clinic, I provided structured diagnostic interviews and individual psychotherapy via telehealth to adult clients in Dallas using empirically-supported treatments such as CBT, ACT, and CPT. Additionally, I conducted symptom-based evaluations of trauma in collaboration with the Human Rights Initiative of Dallas for individuals seeking legal citizenship through the U-VISA program and Violence Against Women Act. 💬Behavioral Activation plus Savoring Study, Dallas, TX
Principal Investigator/Study Therapist | July 2021 – June 2022In this position, I served as the principal study therapist, providing two sessions of brief behavioral activation plus savoring therapy for university students with low positive affect. I also created therapy manuals and homework assignments for a randomized controlled trial and trained master’s-level graduate students in delivering manualized treatment. 📚Veteran’s Association North Texas Health Care System, Dallas, TX Practicum Student | August 2020 – June 2021During my time here, I provided individual psychotherapy via Telehealth utilizing Acceptance and Commitment Therapy to Veterans for symptoms relating to depression, anxiety, and physical health. Additionally, I engaged in individual supervision to enhance competency in providing gender-affirming care. 🔍

Additional Clinical Training Experience and Workshops 🎓

In addition to my clinical experience, I’ve undertaken various training sessions and workshops to enhance my skills and knowledge in the field of psychology:

Positive Affect Treatment Training 🌟Inhibitory Exposure (Negative Affect Treatment Training) 🛑Psychological Assessment Series Training: Millon Multiaxial Clinical Inventory 📝Psychological Assessment Series Training: Personality Assessment Inventory 🧠Comprehensive Behavioral Intervention for Tics 💭Treatment for Affective Disorders 🌈Capnometry-Assisted Respiratory Training 💨Cognitive Processing Therapy for Post-Traumatic Stress Disorder 🧠Integrated Psychosis Assessment Training 🔄Structured Clinical Interview for DSM-5 (SCID-5) Training 💬Training in Applied Behavior Analysis for Children with Autism 🧩

 

Publications Top Notes 📝

 

  1. Enhancing Early Psychosis Treatment Using Smartphone Technology: A Longitudinal Feasibility and Validity Study
    • Journal: Journal of Psychiatric Research, 2018
    • Citations: 117
    • Authors: T.A. Niendam, L.M. Tully, A.M. Iosif, D. Kumar, K.E. Nye, J.C. Denton, …

 

  1. A Mobile Health Platform for Clinical Monitoring in Early Psychosis: Implementation in Community-based Outpatient Early Psychosis Care
    • Journal: JMIR Mental Health, 2018
    • Citations: 75
    • Authors: D. Kumar, L.M. Tully, A.M. Iosif, L.N. Zakskorn, K.E. Nye, A. Zia, T.A. Niendam

 

  1. Social Anxiety and Behavioral Assessments of Social Cognition: A Systematic Review
    • Journal: Journal of Affective Disorders, 2022
    • Citations: 23
    • Authors: T. Alvi, D. Kumar, B.A. Tabak

 

  1. Walking on the Bright Side: Associations Between Affect, Depression, and Gait
    • Journal: PLOS One, 2021
    • Citations: 7
    • Authors: D. Kumar, D.J. Villarreal, A.E. Meuret

 

  1. A Randomized Controlled Trial of Brief Behavioral Activation Plus Savoring for Positive Affect Dysregulation in University Students
    • Journal: Behaviour Research and Therapy, 2024
    • Authors: D. Kumar, S. Corner, R. Kim, A. Meuret

 

Faiyaz Shakeel |Pharmaceutical sciences | Best Researcher Award

Posted on by ScienceFather

 Prof Dr. Faiyaz Shakeel | Pharmaceutical sciences |Best Researcher Award

Prof Dr. King Saud University, Saudi Arabia

👩‍🔬Highly accomplished in pharmaceutics, holds a Ph.D. and M. Pharm. from Jamia Hamdard University, India. With extensive experience as a Professor and Associate Professor at King Saud University, Riyadh, Saudi Arabia, and previous roles in academia and research, he excels in formulation research and development. His expertise spans nanoemulsions and transdermal dosage forms, contributing significantly to the field. Driven by a passion for innovation, he led groundbreaking projects, optimizing drug delivery systems for enhanced therapeutic outcomes. Eager to leverage his skills and knowledge, he seeks to join a renowned research organization, fostering growth and advancement in pharmaceutical sciences.🌟

 

Profile

 

Scholar

 

🎓  Objectives

Seeking association with a renowned research organization in formulation research and development to upgrade knowledge, research, and management skills in line with the latest trends. Eager to be part of a dynamic team contributing to organizational growth.

📚  Qualification Overview

Doctor of Philosophy (Ph.D.) in Pharmaceutics, Jamia Hamdard University, New Delhi, India, 2004-2007. Master of Pharmacy (M. Pharm.) in Pharmaceutics, Jamia Hamdard University, New Delhi, India, 2002-2004. Bachelor of Pharmacy (B. Pharm.), Jamia Hamdard University, New Delhi, India, 1998-2002.

👨‍🏫 Professional Experience

Professor, King Saud University, Riyadh, Saudi Arabia (Feb 2022 – Present) Associate Professor, King Saud University, Riyadh, Saudi Arabia (Mar 2016 – Feb 2022) Assistant Professor, King Saud University, Riyadh, Saudi Arabia (Nov 2011 – Mar 2016) Lecturer, Garyounis University, Benghazi, Libya (Nov 2007 – Nov 2011) Senior Lecturer, Bhawani Shankar Anangpuria Institute of Pharmacy, Faridabad, India (Aug 2006 – Oct 2007) Guest Lecturer, Shri Gopichand College of Pharmacy, Baghpat, India (Jul 2004 – Jun 2006)

🏅  Professional Qualification

Ph.D. Title: Formulation and development of transdermal dosage form (Nanoemulsions) for antirheumatoid drug, Jamia Hamdard University, New Delhi, India, 2004-2007. M. Pharm. Title: Development and evaluation of bioadhesive transdermal gels of diclofenac diethylamine, Jamia Hamdard University, New Delhi, India, 2002-2004. B. Pharm., Jamia Hamdard University, New Delhi, India, 1998-2002.

🔬 Practical Experience

Master’s Research Project: Developed bioadhesive transdermal gels for diclofenac diethylamine. Ph.D. Thesis: Developed nanoemulsion and nanoemulsion gel formulations of celecoxib and aceclofenac for arthritis.

🔍Conclusion of Research Projects

Master’s Project: Optimized gel showed controlled drug release and significant anti-inflammatory effects. Ph.D. Thesis: Developed nanoemulsion formulations with controlled release, higher absorption, and significant pharmacodynamic effects.

Publications Top Notes 📝

  • Development and bioavailability assessment of ramipril nanoemulsion formulation
    • Authors: S Shafiq, F Shakeel, S Talegaonkar, FJ Ahmad, RK Khar, M Ali
    • Journal: European journal of pharmaceutics and biopharmaceutics
    • Year: 2007
    • Volume: 66
    • Issue: 2
    • Pages: 227-243
    • Citations: 1006

 

  • Nanoemulsions as vehicles for transdermal delivery of aceclofenac
    • Authors: F Shakeel, S Baboota, A Ahuja, J Ali, M Aqil, S Shafiq
    • Journal: Aaps Pharmscitech
    • Year: 2007
    • Volume: 8
    • Pages: 191-199
    • Citations: 427

 

  • Formulation development and optimization using nanoemulsion technique: a technical note
    • Authors: S Shafiq-un-Nabi, F Shakeel, S Talegaonkar, J Ali, S Baboota, A Ahuja, …
    • Journal: AAPS pharmscitech
    • Year: 2007
    • Volume: 8
    • Pages: E12-E17
    • Citations: 420

 

  • Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib
    • Authors: S Baboota, F Shakeel, A Ahuja, J Ali, S Shafiq
    • Journal: Acta pharmaceutica
    • Year: 2007
    • Volume: 57
    • Issue: 3
    • Pages: 315-332
    • Citations: 397

 

  • A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives
    • Authors: A Muheem, F Shakeel, MA Jahangir, M Anwar, N Mallick, GK Jain, …
    • Journal: Saudi Pharmaceutical Journal
    • Year: 2016
    • Volume: 24
    • Issue: 4
    • Pages: 413-428
    • Citations: 384

 

Pallab Mandal | Jadavpur University.

Posted on by ScienceFather

Pallab Mandal :Leading Researcher in Jadavpur University.

👨‍🏫 Pallab Mandal , an Mr at Jadavpur University. stands as a distinguished academic and researcher in the  Management and Accounting. Holding PhD Scholar: Pursuing from Jadavpur University Master of Pharmacy: Jadavpur University (2019), India. 🌟Pallab Mandal is a dedicated professional with extensive experience in bio-analytical method development, scientific/medical writing, and profound expertise in breast cancer research. His journey showcases a robust background in pharmaceuticals, with a strong focus on bioequivalence studies, LC-MS/MS analysis, and pharmacokinetic investigations. He possesses a comprehensive skill set in analytical techniques, GLP compliance, and a track record of successful publications and awards in the pharmaceutical domain.

🌐 Professional Profiles:

🎓 Academic Background

PhD Scholar: Pursuing from Jadavpur University Master of Pharmacy: Jadavpur University (2019) ,Bachelor of Pharmacy: Jadavpur University (2015) ,Diploma in Pharmacy: Institute of Pharmacy, Kalyani (2009) Various other diplomas and certifications in related medical fields

🏢 Work Experience

BioAnalyst LC-MS/MS and Head of Quality Assurance: Taab BioStudy Services, Jadavpur (July 2023 – Present)Senior BioAnalyst LC-MS/MS (Lab Incharge): Taab BioStudy Services, Jadavpur (Aug 2015 – July 2023)Teaching experience at Bio-equivalence study center, Jadavpur University (2018 – Present) Pharmacist roles in renowned healthcare facilities.

🏅 Achievements

National Award: M.N. DEV Memorial Award for outstanding performance in D.Pharm final exam International Scientist Award: Recognized as the Best Researcher at INSO Award for Engineering, Science, and Medicine Various awards and accolades for published research papers

🔬 Research & Publications

Diverse research projects focused on bioanalytical method development, pharmacokinetic studies, and drug analysis in human plasma Author of numerous research papers in esteemed national and international journals

📚 Skills & Competencies

Proficient in analytical method development for drug determination in tablets and plasma using HPLC, LC-MS/MS, and various analytical software Expertise in GLP maintenance, validation of developed methods, and analysis of pharmacokinetic data Industrial exposures, workshops, and training in pharmaceutical analysis

Top Noted Publication:

Simultaneous determination and quantitation of diosmetin and hesperetin in human plasma by liquid chromatographic mass spectrometry with an application to pharmacokinetic studies Published on 2019/5/1 Cited by 12

A critical insight of modern herbal drugs therapy under the purview of toxicity and authenticity Published on 2018 Cited by 12

Determination and quantitation of benzofuran, Indole and piperazine containing selective serotonin reuptake inhibitor vilazodone hydrochloride in human plasma by LC-ESI-MS/MS … Published on 2021 Cited by 7

LC-MS/MS method development and validation of an antihistaminic, calcium channel blocker, di-phenyl-methyl-piperazine group containing cinnarizine in human plasma with an …Published on 2018 cited by 5

Repeated dose toxicity study in rats of the formulation containing metformin and sitagliptin using microwave assisted acrylamide grafted cassia tora as polymer Published on 2016/6/1 Cited by 4

Analytical method development and validation of trimethylazanium containing anti-leishmanial phospholipid drug miltefosine by liquid chromatography quadruple tandem mass … Published on2016/6/1 Cited by 4

Microwave Assisted Acrylamide Grafting on a Natural Gum Cassia Tora: Characterization and Pharmacokinetic Evaluation of the Formulation Containing Metformin and Sitagliptin in …Published on 2022 Cited by 1

Anti-Hypertensive Activity of Some Selected Unani Formulations: An Evidence-Based Approach for Verification of Traditional Unani Claims Using LC-MS/MS for the Evaluation of … Published on 2022/8/8